Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1) - Trial NCT06345963
Access comprehensive clinical trial information for NCT06345963 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Texas Health Science Center, Houston and is currently Not yet recruiting. The study focuses on Schizophrenia. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The University of Texas Health Science Center, Houston
Timeline & Enrollment
N/A
May 01, 2024
May 01, 2030
Primary Outcome
brain microstructural integrity from magnetic resonance imaging (MRI),Resting-state functional connectivity (rsFC) from functional MRI
Summary
Patients with schizophrenia spectrum disorder (SSD) will be exposed to active repetitive
 transcranial magnetic stimulation (rTMS) from H coil for improving white matter integrity.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06345963
Device Trial